Second‐line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline<sup>*</sup>

201090 citationsJournal Articlebronze Open Access

Authors

MC Hosseinipour · University of North Carolina at Chapel Hill

JJ Kumwenda · Blantyre Institute for Community Ophthalmology

Ralf Weigel · Lighthouse Trust

LB Brown · University of North Carolina at Chapel Hill

Dalitso Mzinganjira

Brian Mhango · University of Malawi

JJ Eron · Johns Hopkins University Center for AIDS Research

Abstract

Second-line treatment in Malawi was associated with substantial mortality, morbidity and toxicity but, among survivors, virological outcomes were favourable.

Topics & Keywords

HIV/AIDS drug development and treatment HIV Research and Treatment HIV/AIDS Research and Interventions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: HIV Medicine

Volume 11, Issue 8, pp. 510-518

DOI: 10.1111/j.1468-1293.2010.00825.x

Field-Weighted Citation Impact: 5.65